Intervention

dual x-ray absorptometry

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions6

Lead sponsors shown4

Clinical trials

6 shown

Omega-3 Fatty Acids in Treating Patients With Advanced Prostate CancerNCT00996749 · 2011-05-01

Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone MetastasesNCT00634582 · 2009-01-01

Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast CancerNCT00892515 · 2008-10-01

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3NCT00688246 · 2008-07-10

Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in ChildrenNCT00458588 · 2006-09-01

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical TrialNCT00354302 · 2006-04-24

Common conditions

Breast Cancer4 Osteoporosis2 Healthy, no Evidence of Disease1 Metastatic Cancer1 Prostate Cancer1 Stage III Prostate Cancer1

Leading sponsors

NCIC Clinical Trials Group2 Wake Forest University Health Sciences2 Abramson Cancer Center at Penn Medicine1 Fox Chase Cancer Center1

Trial status mix

COMPLETED4

TERMINATED1

WITHDRAWN1

Phase mix

NA2

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.